Table 1 Demographics, vascular risk factors, stroke subtypes, biochemical and clinical data, admission medication and treatment of the study population

Age, yr

62 ± 14

Gender (% female)

9 (53%)

Race (% Caucasians)

4 (24%)

NIHSS on admission

10 ± 8

Pre-admission modified Rankin Scale

1 ± 1

Cardiovascular risk factors

Hypertension

14 (82%)

DM

10 (59%)

Hyperlipidemia

7 (41%)

CAD

4 (24%)

AF

6 (35%)

Previous stroke

2 (12%)

Smoking

2 (12%)

ETOH

3 (18%)

Former cancer

2 (12%)

Illicit drug

1 (6%)

Previous ICH

1 (6%)

Biochemical parameters

WBC number (× 10³/µL)

8.5 ± 3.9

RBC number (×10⁹/µL)

4.56 ± 0.85

Hb, mg/dL

13.2 ± 2.7

Ht, %

39.9 ± 7.2

SBP, mmHg

153 ± 33

DBP, mmHg

88 ± 18

Glucose level, mg/dl

179 ± 107

Platelets number (×10⁹/µL)

265 ± 63

INR

1.1 ± 0.3

Medication on admission

Statins

5 (29%)

Aspirin

6 (35%)

Coumadin

2 (12%)

ACE blockers

4 (24%)

ARB Βeta-blockers Insulin

3 (18%) 5 (30%) 3 (18%)

Intervention/rtPA (IV)

5/3 (29%/18%)